中穎電子(300327.SZ)一季度淨利潤預增33.2%-42.7%
格隆匯 3 月 30日丨中穎電子(300327.SZ)公佈,預計2021年第一季度歸屬於上市公司股東的淨利潤5600萬元-6000萬元,同比增長33.2%-42.7%;扣除非經常性損益後的淨利潤5548萬元-5948萬元,同比增長53.5%-64.6%。
報吿期內,公司銷售收入同比快速增長,綜合毛利率同比提升,帶動公司盈利增長。客户訂單需求旺盛,銷售業績主要受限於上游產能供給;銷售增長較快的產品主要為鋰電池管理芯片及AMOLED顯示驅動芯片。毛利率同比提升,主要受益於產品銷售組合變化及售價變動影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.